Pursuant to regulation 29 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, Coral Laboratories has informed that the Meeting of Board of Director for purpose of adopting Unaudited Financial Result for the quarter ended 30th June, 2017 will be held on Thursday 10th August, 2017 at 11.30 a.m. For the purpose of same the trading window for dealing in securities will remain closed from 3rd August, 2017 to 12th August, 2017.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1874.05 |
| Dr. Reddys Lab | 1284.80 |
| Cipla | 1335.00 |
| Zydus Lifesciences | 936.80 |
| Lupin | 2252.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: